Rossenmorris9620

Z Iurium Wiki

Verze z 5. 11. 2024, 19:40, kterou vytvořil Rossenmorris9620 (diskuse | příspěvky) (Založena nová stránka s textem „[This corrects the article DOI 10.1016/S2665-9913(20)30304-0.].Dietary assessment traditionally relies on self-reported data which are often inaccurate and…“)
(rozdíl) ← Starší verze | zobrazit aktuální verzi (rozdíl) | Novější verze → (rozdíl)

[This corrects the article DOI 10.1016/S2665-9913(20)30304-0.].Dietary assessment traditionally relies on self-reported data which are often inaccurate and may result in erroneous diet-disease risk associations. We illustrate how urinary metabolic phenotyping can be used as alternative approach for obtaining information on dietary patterns. We used two multi-pass 24-hr dietary recalls, obtained on two occasions on average three weeks apart, paired with two 24-hr urine collections from 1,848 U.S. individuals; 67 nutrients influenced the urinary metabotype measured with 1H-NMR spectroscopy characterized by 46 structurally identified metabolites. click here We investigated the stability of each metabolite over time and showed that the urinary metabolic profile is more stable within individuals than reported dietary patterns. The 46 metabolites accurately predicted healthy and unhealthy dietary patterns in a free-living U.S. cohort and replicated in an independent U.K. cohort. We mapped these metabolites into a host-microbial metabolic network to identify key pathways and functions. These data can be used in future studies to evaluate how this set of diet-derived, stable, measurable bioanalytical markers are associated with disease risk. This knowledge may give new insights into biological pathways that characterize the shift from a healthy to unhealthy metabolic phenotype and hence give entry points for prevention and intervention strategies.MLL is a target of chromosomal translocations in acute leukemias with poor prognosis. The common MLL fusion partner AF9 (MLLT3) can directly bind to AF4, DOT1L, BCOR, and CBX8. To delineate the relevance of BCOR and CBX8 binding to MLL-AF9 for leukemogenesis, here we determine protein structures of AF9 complexes with CBX8 and BCOR, and show that binding of all four partners to AF9 is mutually exclusive. Using the structural analyses, we identify point mutations that selectively disrupt AF9 interactions with BCOR and CBX8. In bone marrow stem/progenitor cells expressing point mutant CBX8 or point mutant MLL-AF9, we show that disruption of direct CBX8/MLL-AF9 binding does not impact in vitro cell proliferation, whereas loss of direct BCOR/MLL-AF9 binding causes partial differentiation and increased proliferation. Strikingly, loss of MLL-AF9/BCOR binding abrogated its leukemogenic potential in a mouse model. The MLL-AF9 mutant deficient for BCOR binding reduces the expression of the EYA1 phosphatase and the protein level of c-Myc. Reduction in BCOR binding to MLL-AF9 alters a MYC-driven gene expression program, as well as altering expression of SIX-regulated genes, likely contributing to the observed reduction in the leukemia-initiating cell population.The most common genetic abnormality in multiple myeloma (MM) is the deletion of chromosome 13, seen in almost half of newly diagnosed patients. Unlike chronic lymphocytic leukemia, where a recurrent minimally deleted region including MIR15A/MIR16-1 has been mapped, the deletions in MM predominantly involve the entire chromosome and no specific driver gene has been identified. Additional candidate loci include RB1 and DIS3, but while biallelic deletion of RB1 is associated with disease progression, DIS3 is a common essential gene and complete inactivation is not observed. The Vk*MYC transgenic mouse model of MM spontaneously acquires del(14), syntenic to human chromosome 13, and Rb1 complete inactivation, but not Dis3 mutations. Taking advantage of this model, we explored the role in MM initiation and progression of two candidate loci on chromosome 13 RB1 and MIR15A/MIR16-1. Monoallelic deletion of Mir15a/Mir16-1 but not Rb1 was sufficient to accelerate the development of monoclonal gammopathy in wildtype mice, and the progression of MM in Vk*MYC mice, resulting in increased expression of Mir15a/Mir16-1 target genes and plasma cell proliferation, which was similarly observed in patients with MM.Low-dimensional metal halides have been the focus of intense investigations in recent years following the success of hybrid lead halide perovskites as optoelectronic materials. In particular, the light emission of low-dimensional halides based on the 5s2 cations Sn2+ and Sb3+ has found utility in a variety of applications complementary to those of the three-dimensional halide perovskites because of its unusual properties such as broadband character and highly temperature-dependent lifetime. These properties derive from the exceptional chemistry of the 5s2 lone pair, but the terminology and explanations given for such emission vary widely, hampering efforts to build a cohesive understanding of these materials that would lead to the development of efficient optoelectronic devices. In this Perspective, we provide a structural overview of these materials with a focus on the dynamics driven by the stereoactivity of the 5s2 lone pair to identify the structural features that enable strong emission. We unite the different theoretical models that have been able to explain the success of these bright 5s2 emission centers into a cohesive framework, which is then applied to the array of compounds recently developed by our group and other researchers, demonstrating its utility and generating a holistic picture of the field from the point of view of a materials chemist. We highlight those state-of-the-art materials and applications that demonstrate the unique capabilities of these versatile emissive centers and identify promising future directions in the field of low-dimensional 5s2 metal halides.Halides of ns2 metal ions have recently regained broad research interest as bright narrowband and broadband emitters. Sb(III) is particularly appealing for its oxidative stability (compared to Ge2+ and Sn2+) and low toxicity (compared to Pb2+). Square pyramidal SbX5 anion had thus far been the most common structural motif for realizing high luminescence efficiency, typically when cocrystallized with an organic cation. Luminescent hybrid organic-inorganic halides with octahedral coordination of Sb(III) remain understudied, whereas fully inorganic compounds show very limited structural engineerability. We show that the host-guest complexation of alkali metal cations with crown ethers fosters the formation of zero-dimensional Sb(III) halides and allows for adjusting the coordination number (5 or 6). The obtained compounds exhibit bright photoluminescence with quantum yields of up to 89% originating from self-trapped excitons, with emission energies, Stokes shifts, and luminescence lifetimes finely-adjustable by structural engineering.

Autoři článku: Rossenmorris9620 (Neergaard Dobson)